Delayed Puberty In Kallmann Syndrome: The Impact On Physical Development
Published on: July 24, 2025
Delayed Puberty In Kallmann Syndrome: The Impact On Physical Development
Article author photo

Malvin Maneth

Bachelor of Science - BS, Biomedical Health, University of Derby

Article reviewer photo

Daisy Porter

Bachelor of Science in Biotechnology and Microbiology

What is kallmann syndrome?

KS is a rare genetic disorder that interferes with the body’s ability to start puberty naturally and, in most cases, affects the sense of smell. It falls under a group of disorders called hypogonadotropic hypogonadism (HH).1 In simple terms, the brain doesn’t produce enough of a hormone called Gonadotropin-Releasing Hormone (GnRH), which is the signal that tells the body to start producing sex hormones. Without GnRH, the pituitary gland doesn’t make enough Luteinising Hormone (LH) and Follicle-Stimulating Hormone (FSH), which are crucial for puberty and fertility.2

A unique characteristic that sets KS apart from other types of HH  is an absence of smell (anosmia) or an impaired sense of smell (hyposmia). This occurs because the neurons responsible for both smell and hormone regulation develop together in the womb. If they don’t reach their final destination in the brain, both puberty and the sense of smell are affected.3

The causes of KS?

The primary cause is genetic mutations that disrupt the migration of GnRH-producing and olfactory (smell) neurons from the nasal region to the brain during early development.

Over 20 different genes have been linked to KS. Some of the more renowned include:2 4

  • KAL1: One of the first identified KS genes, and it is located on the X chromosome. It codes for a protein called anosmin-1, which is required for nerve cell adhesion and GnRH neuron migration
  • FGFR1: Loss-of-function mutations impair signalling, leading to defective GnRH neuron differentiation and migration
  • CHD7 & PROK2/PROKR2: Involved in neuron migration and olfactory bulb development

Inheritance patterns

  • X-linked recessive (KAL1): More common and severe in males; females are typically asymptomatic carriers
  • Autosomal dominant (FGFR1): May exhibit incomplete penetrance, meaning not everyone with the gene mutation expresses symptoms
  • Sporadic cases: Approximately 60% of KS cases have no family history, suggesting de novo (brand new) mutations5

Who is affected?

KS affects both sexes, but it is five times more common in the males sex. It is estimated to affect approximately 1 in 10,000 people assigned male at birth (AMAB) and 1 in 50,000 people assigned female at birth (AFAB).6

Although the genetic mutations responsible for KS are present from birth, the condition often goes undiagnosed until puberty, when expected physical changes fail to occur. In some cases, diagnosis may be delayed until adulthood, often during evaluations for infertility.7 This is particularly common in females, where symptoms tend to be subtler. Signs such as absent menstruation or lack of breast development may be mistaken for other hormonal issues, contributing to delayed recognition of the condition.8 9

Signs and symptoms

KS doesn’t look the same for everyone. Some signs appear at birth, while others become clear during adolescence when puberty fails to start. Symptoms can be grouped into:10 11 12

Reproductive

  • Low libido (sex drive)
  • Delayed/absent puberty: No growth spurt, lack of secondary sexual characteristics by age 13 in people assigned female at birth, 14 in people assigned male at birth.

Male sex

  • Micropenis or undescended testes (cryptorchidism) at birth
  • Lack of facial/body hair, voice deepening, or muscle development
  • Infertility due to low or no sperm production

Female sex

  • Absent thelarche (breast development)
  • Primary amenorrhoea (no first period by age 16)
  • Infertility due to absent ovulation

Physical

  • Anosmia/hyposmia: characteristic feature
  • Eunuchoid body proportions: Long limbs and short torso due to delayed bone maturation
  • Weak bone density: Increased risk of osteoporosis
  • Cleft lip/palate
  • Renal agenesis (development of only one kidney)
  • Hearing loss, colour blindness, abnormal eye movements, or teeth development

Psychological

  • Low self-esteem or social withdrawal due to delayed development.
  • Depression, anxiety or mood swings, often linked to hormonal imbalance and social stigma.
  • Body image concerns: Feeling “childlike” in appearance and “left behind” compared to peers.

How is KS diagnosed?

Often performed in adolescence when puberty fails to initiate, there is no single test to confirm KS, but a combination of:13

  • Clinical signs: Lack of pubertal signs by age 13 in the female sex or 14 in the male sex, combined with impaired sense of smell
  • Blood tests: Low LH, FSH, and sex hormones (testosterone or oestrogen)
  • MRI scan: To examine the hypothalamus and olfactory bulbs. In KS, these bulbs may be underdeveloped or absent
  • Genetic testing: Can identify specific gene mutations and can help with family planning

Management & treatment

KS is a lifelong condition, but its effects can be managed effectively with treatment tailored to each individual’s needs and goals.14,15

Hormone replacement therapy (HRT)

The primary method of treatment, used to induce and maintain puberty, support sexual development, and prevent long-term complications such as osteoporosis.

  • Assigned male at birth (AFAB): Testosterone is administered via injections, patches, or gels to improve bone health and promote secondary sexual characteristics, including voice deepening, facial and body hair growth, and increased muscle mass
  • Assigned Female at birth (AMAB): Oestrogen and progesterone are provided through pills or patches to improve bone health, trigger menstruation, support uterine health, and promote secondary sexual characteristics such as breast development and body hair growth

Fertility treatment

HRT alone does not restore fertility. To stimulate sperm or egg production, it requires additional hormone therapy.

  • GnRH: Delivered via injections or a small pump (pulsatile therapy), GnRH stimulates the pituitary gland to produce LH and FSH
  • Human Chorionic Gonadotropin (hCG) injections mimic LH and are often combined with FSH to stimulate the ovaries and testes directly

Both GnRH and hCG are often used in combination to maximise reproductive function. In AFAB people, they help induce ovulation and menstruation. In AMAB people, they promote testosterone production and stimulate spermatogenesis (sperm production).

However, fertility treatments do not work for everyone. For individuals who do not respond to hormonal therapies or who face additional fertility challenges, assisted reproductive techniques (ART), such as in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI), may be recommended.16 17

Surgery

Sometimes necessary to correct physical abnormalities associated with KD, such as hearing loss, undescended testicles or a cleft lip/palate.

Psychological support

Delayed puberty and infertility can significantly impact emotional and mental well-being, especially during adolescence. Counselling, therapy, or peer support groups can play a crucial role in helping individuals cope with these challenges, build confidence, and improve quality of life.

Lifestyle and monitoring

  • Regular follow-ups with an endocrinologist to monitor bone health, adjust hormone levels, and evaluate the effectiveness of fertility treatments
  • Healthy habits: Diets rich in calcium and vitamin D, along with weight-bearing exercises, can improve bone health and promote overall physical health18

FAQs

Can KS be cured?

KS cannot be cured, but it can be effectively managed with lifelong HT and fertility treatment. With proper care, many people go on to lead normal, healthy lives.

Is the lack of smell permanent?

Unfortunately, yes. Anosmia or hyposmia is a lifelong and hallmark feature of KS. It results from the underdevelopment or absence of the olfactory bulbs, which occurs during early brain development in the womb. At present, there is no treatment available to restore the sense of smell.

Is it possible to detect KS before puberty?

Yes, in some cases. Clues such as an absent sense of smell, undescended testes in baby males, or a family history of delayed puberty or infertility may raise early suspicion. However, most diagnoses are still made during adolescence when puberty fails to start.

Is it possible for someone with KS to conceive naturally?

HRT may help some individuals regain fertility, but natural conception isn’t guaranteed. ARTs, like IVF or sperm/egg retrieval, may be necessary for those who do not fully respond to HT. With the right care and assistance, many people with KS can have biological children despite the difficulties.

Summary

Kallmann Syndrome is a rare but manageable genetic disorder that impacts physical development and fertility and delays or halts puberty. It is brought on by the lack of GnRH, a hormone that sets off a cascade of changes associated with puberty. Although living with KS can be challenging, healthy development, emotional stability, and even parenthood may result from early diagnosis and proper care.

References

  1. Hilman S, Dewi DK, Kartika E. A rare disease of Kallmann syndrome: A case report. Radiology Case Reports [Internet]. Elsevier BV; 2023 [cited 2025 May 10]; 18(3):1232–8. Available from: https://www.sciencedirect.com/science/article/pii/S1930043322011050
  2. Stamou MI, Georgopoulos NA. Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism. Metabolism [Internet]. Elsevier BV; 2018 [cited 2025 May 10]; 86:124–34. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5934335
  3. Kałużna M, Budny B, Rabijewski M, Kałużny J, Dubiel A, Trofimiuk-Müldner M, et al. Defects in GnRH Neuron Migration/Development and Hypothalamic-Pituitary Signaling Impact Clinical Variability of Kallmann Syndrome. Genes [Internet]. MDPI AG; 2021 [cited 2025 May 10]; 12(6):868. Available from: https://www.mdpi.com/2073-4425/12/6/868
  4. Swee DS, Quinton R, Maggi R. Recent advances in understanding and managing Kallmann syndrome. Faculty Reviews [Internet]. Faculty Opinions Ltd; 2021 [cited 2025 May 10]; 10. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8130407/
  5. Laitinen E-M, Vaaralahti K, Tommiska J, Eklund E, Tervaniemi M, Valanne L, et al. Incidence, Phenotypic Features and Molecular Genetics of Kallmann Syndrome in Finland. Orphanet Journal of Rare Diseases [Internet]. Springer Science and Business Media LLC; 2011 [cited 2025 May 12]; 6(1). Available from: https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-6-41
  6. Kashima T, Ishimaru M, Tanimoto E, Fukui S, Nakamura C, Ujita N, et al. 7802 A Review of 21 Cases of Kallmann Syndrome. Journal of the Endocrine Society [Internet]. The Endocrine Society; 2024 [cited 2025 May 10]; 8(Supplement_1). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11455385/
  7. Kaplan JD, Bernstein JA, Kwan A, Hudgins L. Clues to an early diagnosis of Kallmann syndrome. American Journal of Medical Genetics Part A [Internet]. Wiley; 2010 [cited 2025 May 12]; 152A(11):2796–801. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.33442
  8. Jahan S, Shermin S, Habib SH, Nayer R. Kallmann’s Syndrome: A Rare Cause of Primary Amenorrhoea. Gynecology & Obstetrics [Internet]. OMICS Publishing Group; 2014 [cited 2025 May 12]; 04(09). Available from: https://www.longdom.org/open-access/kallmann8217s-syndrome-a-rare-cause-of-primary-amenorrhoea-39440.html
  9. Qamar A, Sagalla N, Weaver A, Crowley M. SAT-212 62-Year-Old Woman with Undiagnosed Kallman Syndrome: A Case of Missed Opportunities. Journal of the Endocrine Society [Internet]. Endocrine Society; 2019 [cited 2025 May 12]; 3(Supplement_1). Available from: https://academic.oup.com/jes/article/3/Supplement_1/SAT-212/5483797
  10. National Organization for Rare Disorders. Kallmann Syndrome. In: rarediseases.org [Internet]. 2015 [cited 2025 May 9]. Available from: https://rarediseases.org/rare-diseases/kallmann-syndrome/#symptoms
  11. Children's Hospital of Philadelphia. Kallmann Syndrome. In: chop.edu [Internet]. 2025 [cited 2025 May 9]. Available from: https://www.chop.edu/conditions-diseases/kallmann-syndrome
  12. Dwyer AA, Smith N, Quinton R. Psychological Aspects of Congenital Hypogonadotropic Hypogonadism. Frontiers in Endocrinology [Internet]. Frontiers Media SA; 2019 [cited 2025 May 9]; 10. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6624645/
  13. National Organization for Rare Disorders. Kallmann Syndrome. In: rarediseases.org [Internet]. 2015 [cited 2025 May 15]. Available from: https://rarediseases.org/rare-diseases/kallmann-syndrome/#diagnosis
  14. Boehm U, Bouloux P-M, Dattani MT, Roux N de, Dodé C, Dunkel L, et al. European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment. Nature Reviews Endocrinology [Internet]. Nature Portfolio; 2015 [cited 2025 May 18]; 11(9):547–64. Available from: https://www.nature.com/articles/nrendo.2015.112
  15. Hofmann J, Watzlawik M, Richter-Appelt H. Living with Kallmann Syndrome – Analysis of Subjective Experience Reports from Women. Geburtshilfe und Frauenheilkunde [Internet]. Thieme Medical Publishers (Germany); 2013 [cited 2025 May 18]; 73(11):1112–20. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3862043/
  16. Gao Y, Yu B, Mao J, Wang X, Nie M, Wu X. Assisted reproductive techniques with congenital hypogonadotropic hypogonadism patients: a systematic review and meta-analysis. BMC Endocrine Disorders [Internet]. Springer Science and Business Media LLC; 2018 [cited 2025 May 21]; 18(1). Available from: https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-018-0313-8
  17. Shiraiwa A, Takahashi T, Okoshi C, Wada M, Ota K, Suganuma R, et al. Successful pregnancy and delivery after a vitrified-warmed embryo transfer in a woman with Kallmann syndrome: A case report and literature review. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE [Internet]. 2022 [cited 2025 May 21]; 68(1):49–55. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9071358/
  18. Iolascon G, Frizzi L, Bianco M, Gimigliano F, Palumbo V, Sinisi AM, et al. Bone involvement in males with Kallmann disease. Aging Clinical and Experimental Research [Internet]. Springer Science+Business Media; 2015 [cited 2025 May 21]; 27(S1):31–6. Available from: https://link.springer.com/article/10.1007/s40520-015-0421-5
Share

Malvin Maneth

Bachelor of Science (Honours) in Biomedical Health

arrow-right